Evidence map›Paper›PMID 36536628›Full record

ArticlePeerJ2022

The rhythm of chemotherapy and cancer patients' time perspectives.

Marcin Moskalewicz, Piotr Kordel, Anna Sterna

Abstract read
In one paragraph

Article in PeerJ, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. The relationship between time perspective and fear of cancer recurrence among Chinese gastric cancer patients: the chain mediating role of rumination and catastrophizing.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2025
    Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Marcin MoskalewiczPhilosophy and Mental Health Unit, Department of Social Sciences and the Humanities, Poznań University of Medical Sciences, Poznań, Wielkopolskie, Poland.
Piotr KordelPhilosophy and Mental Health Unit, Department of Social Sciences and the Humanities, Poznań University of Medical Sciences, Poznań, Wielkopolskie, Poland.
Anna SternaPhilosophy and Mental Health Unit, Department of Social Sciences and the Humanities, Poznań University of Medical Sciences, Poznań, Wielkopolskie, Poland.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: While it is well known that illnesses such as cancer modify the experience of time, the impact of the rhythm and length of treatment on patients' time perspectives remains unknown. Methods: A short version of Zimbardo Time Perspective Inventory and Transcendental Future Perspective Questionnaire as well as a demographic questionnaire on a convenience sample of 259 patients (66.8% female, mean age 52.36) with various cancers and undergoing chemotherapy with different frequencies (1, 2, 3 weeks) and mean time in treatment 23.4 months. Results: The temporal perspectives mean scores of cancer patients are: positive past 3.69, negative past 3.13, present hedonism 3.08, future 3.77, transcendental future 3.40. Patients tend only slightly to lose faith alongside the course of oncological treatment regardless of their age ( Conclusions: The variations of treatment rhythm are less significant than predicted, although still relevant. Since most sociodemographic variables are of no relevance, cancer experience likely unifies temporal perspectives among people of different backgrounds.

Indexed as

NeoplasmsTime PerceptionFemaleForecastingHumansMaleMiddle AgedTimeChemotherapyTemporal experienceTranscendental-Future Time Perspective InventoryZimbardo Time Perspective Inventory

Identifiers

PMID36536628
PMCPMC9758969

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.